RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. Cash from financing

ABEONA THERAPEUTICS INC.ABEO

Market cap
$255.78M
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 2024104+181.02%
Dec 31, 202337-14.17%
Dec 31, 202243+73.66%
Dec 31, 202125+1184.14%
Dec 31, 20202-98.30%
Dec 31, 2019114+1979.64%
Dec 31, 20185-94.07%
Dec 31, 201792+117.23%
Dec 31, 201643+19.31%
Dec 31, 201536+180.57%
Dec 31, 201413+43717.24%
Dec 31, 20130-98.48%
Dec 31, 20122-38.10%
Dec 31, 20113

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)